Common Stock, $0.0001 par value
- Symbol
- CLNN
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 8.01, 9.01 · 8-K
Clene Inc.
CLNNNASDAQEQUITYCurrent
Other Events
Item 8.01 Other Events. On January 12, 2026, Clene Inc. issued a press release announcing additional CNM-Au8® biomarker data supporting a potential new drug application (“NDA”) filing for an upcoming in-person meeting with the U.S. Food and Drug Administration (“FDA”). A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Company context
Current securities
Registered securities in this filing
CLENE INC. · 8-K · Filed 2026-01-12
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events.
On January 12, 2026, Clene Inc. issued a press release announcing additional CNM-Au8® biomarker data supporting a potential new drug application (“NDA”) filing for an upcoming in-person meeting with the U.S. Food and Drug Administration (“FDA”). A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.